Skip to main content

Table 1 Change in binding free energy related to mutations in receptor-binding domain of the spike protein

From: Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

Wild type

Position

Mutant type

Mutants

Distance to interface

ΔΔGwild-mutation (kcal/mol)

Affinity

From 26 December, 2019 to 8 March, 2020

 ARG

509

LYS

R509K

15.117

-0.78

Decreasing

 PHE

338

LEU

F338L

25.998

-0.776

Decreasing

 TYR

508

HIS

Y508H

8.916

-0.595

Decreasing

 GLU

516

GLN

E516Q

32.457

-0.556

Decreasing

 HIS

519

PRO

H519P

40.899

-0.534

Decreasing

 HIS

519

GLN

H519Q

40.899

-0.502

Decreasing

 GLY

476

SER

G476S

3.806

-0.433

Decreasing

 ASN

439

LYS

N439K

7.234

-0.331

Decreasing

 ASP

467

VAL

D467V

14.986

-0.291

Decreasing

 VAL

510

LEU

V510L

16.548

-0.27

Decreasing

 GLN

409

GLU

Q409E

9.46

-0.253

Decreasing

 LYS

378

ARG

K378R

19.35

-0.245

Decreasing

 ARG

408

ILE

R408I

10.586

-0.199

Decreasing

 ASP

405

VAL

D405V

7.48

-0.196

Decreasing

 ILE

468

THR

I468T

14.973

-0.177

Decreasing

 ILE

472

VAL

I472V

8.123

-0.177

Decreasing

 SER

477

GLY

S477G

4.97

-0.172

Decreasing

 GLY

446

VAL

G446V

3.279

-0.158

Decreasing

 GLN

414

ALA

Q414A

15.173

-0.118

Decreasing

 LYS

458

ASN

K458N

9.745

-0.089

Decreasing

 VAL

483

ALA

V483A

9.719

-0.053

Decreasing

 SER

438

PHE

S438F

11.54

-0.039

Decreasing

 VAL

483

ILE

V483I

9.719

-0.026

Decreasing

 ALA

372

SER

A372S

15.674

-0.023

Decreasing

 ASP

364

TYR

D364Y

28.736

-0.021

Decreasing

 ALA

475

VAL

A475V

2.813

-0.001

Decreasing

 ALA

522

VAL

A522V

41.819

0.024

Increasing

 PRO

491

ARG

P491R

6.013

0.033

Increasing

 LYS

458

ARG

K458R

9.745

0.042

Increasing

 VAL

341

ILE

V341I

23.363

0.045

Increasing

 ALA

522

SER

A522S

41.819

0.088

Increasing

 ALA

435

SER

A435S

15.197

0.148

Increasing

 ASN

354

ASP

N354D

20.704

0.168

Increasing

 ALA

520

SER

A520S

42.138

0.177

Increasing

 ALA

348

THR

A367T

16.047

0.204

Increasing

 VAL

367

PHE

V367F

23.608

0.235

Increasing

 GLN

414

GLU

Q414E

15.173

0.252

Increasing

 ILE

468

PHE

I468F

14.973

0.256

Increasing

From 9 March, 2020 to 30 November, 2020

 PHE

490

LEU

F490L

3.825

-0.791

Decreasing

 LYS

417

ARG

K417R

2.862

-0.487

Decreasing

 ASN

439

LYS

N439K§

7.234

-0.331

Decreasing

 ASN

354

LYS

N354K

20.704

-0.294

Decreasing

 PHE

490

SER

F490S

3.825

-0.239

Decreasing

 SER

373

LEU

S373L

14.013

-0.203

Decreasing

 VAL

382

LEU

V382L

30.232

-0.202

Decreasing

 GLU

484

LYS

E484K

4.184

-0.154

Decreasing

 THR

385

ILE

T385I

28.446

-0.128

Decreasing

 ARG

408

LYS

R408K

10.586

-0.127

Decreasing

 SER

494

PRO

S494P

6.031

-0.095

Decreasing

 VAL

483

ALA

V483A

9.719

-0.053

Decreasing

 THR

478

LYS

T478K

7.571

-0.028

Decreasing

 ALA

475

VAL

A475V§

2.813

-0.001

Decreasing

 PRO

384

SER

P384S

26.132

0.01

Increasing

 SER

469

PRO

S469P

12.248

0.02

Increasing

 SER

459

TYR

S459Y

11.205

0.02

Increasing

 ARG

346

LYS

R346K

16.314

0.022

Increasing

 ASN

354

SER

N354S

20.704

0.033

Increasing

 PRO

521

ARG

P521R

42.427

0.036

Increasing

 SER

514

PHE

S514F

26.529

0.041

Increasing

 ALA

522

SER

A522S§

41.819

0.088

Increasing

 SER

477

ASN

S477N

4.97

0.227

Increasing

 VAL

367

PHE

V367F§

23.608

0.235

Increasing

 ALA

522

GLU

A522E

41.819

0.409

Increasing

 ASN

501

THR

N501T

3.115

0.87

Increasing

  1. §These four mutations were also predicted in early stage